DE:N040 Stock Latest News
Company AnnouncementsNuCana Wins Key European Patent for Lead Cancer Drug NUC-77381M ago6KNCNA
Company AnnouncementsNuCana Files Q2 2026 Results and Updates U.S. Registration Statements2M ago6KNCNA
Company AnnouncementsNuCana Shareholders Approve All Resolutions at June 2026 AGM4M ago6KNCNA
The FlyNuCana appoints Ian Webster as CFO5M agoNCNA
Company AnnouncementsNuCana Confirms Ian Webster as CFO to Steer Oncology Pipeline Through Key 2026 Milestones5M ago6KNCNACompany AnnouncementsNuCana Sets June 8 AGM, Seeks Share Capital Restructuring and Fresh Funding Authorities5M ago6KNCNA
Company AnnouncementsNuCana Posts 2025 Results, Highlights NUC-7738 Progress and Cash Runway Into 20297M ago6KNCNA- Company AnnouncementsNuCana Names Theresa Bruce Chief Operating Officer to Drive Oncology Pipeline9M ago6KNCNA
The FlyNuCana appoints Bruce as COO9M agoNCNA- Company AnnouncementsNuCana Announces Return of CEO Hugh S. Griffith Following Health Leave10M ago6KNCNA
Company AnnouncementsNuCana Showcases Promising Results for NUC-7738 in Melanoma Treatment10M ago6KNCNA
- Company AnnouncementsNuCana Reports Q3 2025 Financial Results and Board Resignation11M ago6KNCNA
Company AnnouncementsNuCana Secures Key Patent for NUC-7738 in China12M ago6KNCNA
Company AnnouncementsNuCana Presents Promising Data on NUC-7738 at ESMO Congress 20251y ago6KNCNA
